Literature DB >> 15842766

Telomere and telomerase as targets for anti-cancer and regeneration therapies.

Yi-hsin Hsu1, Jing-jer Lin.   

Abstract

Telomerase is a ribonucleoprotein that directs the synthesis of telomeric sequence. It is detected in majority of malignant tumors, but not in most normal somatic cells. Because telomerase plays a critical role in cell immortality and tumor formation, it has been one of the targets for anti-cancer and regeneration drug development. In this review, we will discuss therapeutic approaches based mainly on small molecules that have been developed to inhibit telomerase activity, modulate telomerase expression, and telomerase directed gene therapy.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15842766     DOI: 10.1111/j.1745-7254.2005.00098.x

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  5 in total

1.  Curcumin regulates low-linear energy transfer γ-radiation-induced NFκB-dependent telomerase activity in human neuroblastoma cells.

Authors:  Natarajan Aravindan; Jamunarani Veeraraghavan; Rakhesh Madhusoodhanan; Terence S Herman; Mohan Natarajan
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-01-13       Impact factor: 7.038

2.  Induction of senescence in cancer cells by the G-quadruplex stabilizer, BMVC4, is independent of its telomerase inhibitory activity.

Authors:  Fong-Chun Huang; Cheng-Chung Chang; Jing-Min Wang; Ta-Chau Chang; Jing-Jer Lin
Journal:  Br J Pharmacol       Date:  2012-09       Impact factor: 8.739

3.  The antitumor efficacy of anti-p21Ras scFv mediated by the dual-promoter-regulated recombinant adenovirus KGHV300.

Authors:  X Y Pan; X J Liu; J Li; S J Zhen; D X Liu; Q Feng; W X Zhao; Y Luo; Y L Zhang; H W Li; J L Yang
Journal:  Gene Ther       Date:  2016-12-22       Impact factor: 5.250

4.  Transcriptional down regulation of hTERT and senescence induction in HepG2 cells by chelidonine.

Authors:  Sakineh Kazemi Noureini; Michael Wink
Journal:  World J Gastroenterol       Date:  2009-08-07       Impact factor: 5.742

5.  Early growth response protein-1 promoter-mediated synergistic antitumor effect of hTERTC27 gene therapy and 5-Flurorouracil on nasopharyngeal carcinoma.

Authors:  Guimiao Lin; Marie Chia-Mi Lin; Suxia Lin; Hong Yao; Shuihong Yu; Wanxian Yi; Gaixia Xu; Samuel Sai-Ming Ng; Siping Chen; Jing Yu; Xiaomei Wang; Baoxue Yang
Journal:  Cancer Biother Radiopharm       Date:  2012-09       Impact factor: 3.099

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.